In human coronary arteries, atherosclerotic plaques tend to spread downstream because of the changes in blood flow patterns the plaque causes, researchers have found.

This insight comes from a study of fluid dynamics in the arteries of people being treated for coronary artery disease. The results are being presented Tuesday, Nov. 15 at the…    



Hormone that controls iron levels may be target for atherosclerosis treatment

Researchers at Emory University School of Medicine have identified hepcidin, a hormone that regulates iron levels in the body, as a potential target for treating atherosclerosis.

Suppressing hepcidin is a way to reduce the iron levels inside the white blood cells found in arterial plaques. Reducing iron levels pushes those cells to clean up…